PFIZER INC Cash and Cash Equivalents, Period Increase (Decrease)
PFIZER INC (PFE) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$1.25 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-22
- PFIZER INC cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$1.44B, a 387.03% decline year-over-year.
- PFIZER INC cash and cash equivalents, period increase (decrease) for the quarter ending 2017-10-01 was $194.00M.
- PFIZER INC cash and cash equivalents, period increase (decrease) for the quarter ending 2017-07-02 was -$1.47B, a 273.06% decline year-over-year.
- PFIZER INC cash and cash equivalents, period increase (decrease) for the quarter ending 2017-04-02 was $1.46B.
- PFIZER INC cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$1.25B.
- PFIZER INC cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.05B, a 451.01% decline from fiscal 2015.
- PFIZER INC cash and cash equivalents, period increase (decrease) for fiscal 2015 was $298.00M, a 74.31% decline from fiscal 2014.
- PFIZER INC cash and cash equivalents, period increase (decrease) for fiscal 2014 was $1.16B.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | -$1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$1.24B derived: sum of 2 quarters · filed 2018-02-22 | -$2.71B derived: sum of 3 quarters · filed 2018-02-22 | -$1.25B 10-K · filed 2018-02-22 | ||
| 2017-10-01 | $194.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.28B derived: sum of 2 quarters · filed 2017-11-09 | $184.00M 10-Q · filed 2017-11-09 | $685.00M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2017-07-02 | -$1.47B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$10.00M 10-Q · filed 2017-08-10 | $491.00M derived: sum of 3 quarters · filed 2018-02-22 | -$826.00M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2017-04-02 | $1.46B 10-Q · filed 2017-05-11 | $1.96B derived: sum of 2 quarters · filed 2018-02-22 | $645.00M derived: sum of 3 quarters · filed 2018-02-22 | $1.50B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-12-31 | $501.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$816.00M derived: sum of 2 quarters · filed 2018-02-22 | $34.00M derived: sum of 3 quarters · filed 2018-02-22 | -$1.05B 10-K · filed 2018-02-22 | ||
| 2016-10-02 | -$1.32B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$467.00M derived: sum of 2 quarters · filed 2017-11-09 | -$1.55B 10-Q · filed 2017-11-09 | -$1.00B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-07-03 | $850.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$230.00M 10-Q · filed 2017-08-10 | $312.00M derived: sum of 3 quarters · filed 2018-02-22 | -$259.00M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-04-03 | -$1.08B 10-Q · filed 2017-05-11 | -$538.00M derived: sum of 2 quarters · filed 2018-02-22 | -$1.11B derived: sum of 3 quarters · filed 2018-02-22 | -$1.00B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2015-12-31 | $542.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$29.00M derived: sum of 2 quarters · filed 2018-02-22 | $78.00M derived: sum of 3 quarters · filed 2018-02-22 | $298.00M 10-K · filed 2018-02-22 | ||
| 2015-09-27 | -$571.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$464.00M derived: sum of 2 quarters · filed 2016-11-10 | -$244.00M 10-Q · filed 2016-11-10 | $661.00M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-28 | $107.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $327.00M 10-Q · filed 2016-08-11 | $1.23B derived: sum of 3 quarters · filed 2017-02-23 | $264.00M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-29 | $220.00M 10-Q · filed 2016-05-12 | $1.13B derived: sum of 2 quarters · filed 2017-02-23 | $157.00M derived: sum of 3 quarters · filed 2017-02-23 | $701.00M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $905.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$63.00M derived: sum of 2 quarters · filed 2017-02-23 | $481.00M derived: sum of 3 quarters · filed 2017-02-23 | $1.16B 10-K · filed 2017-02-23 | ||
| 2014-09-28 | -$968.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$424.00M derived: sum of 2 quarters · filed 2015-11-05 | $255.00M 10-Q · filed 2015-11-05 | $386.00M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-29 | $544.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.22B 10-Q · filed 2015-08-06 | $1.35B derived: sum of 3 quarters · filed 2016-02-29 | $970.00M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-30 | $679.00M 10-Q · filed 2015-05-07 | $810.00M derived: sum of 2 quarters · filed 2016-02-29 | $426.00M derived: sum of 3 quarters · filed 2016-02-29 | $970.00M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $131.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$253.00M derived: sum of 2 quarters · filed 2016-02-29 | $291.00M derived: sum of 3 quarters · filed 2016-02-29 | -$7.90B 10-K · filed 2016-02-29 | ||
| 2013-09-29 | -$384.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $160.00M derived: sum of 2 quarters · filed 2014-11-06 | -$8.03B 10-Q · filed 2014-11-06 | -$2.45B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $544.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$7.64B 10-Q · filed 2014-08-07 | -$2.07B derived: sum of 3 quarters · filed 2015-02-27 | -$595.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | -$8.19B 10-Q · filed 2014-05-08 | -$8.26B 10-Q · filed 2013-05-10 | -$2.61B derived: sum of 2 quarters · filed 2015-02-27 | -$1.14B derived: sum of 3 quarters · filed 2015-02-27 | -$1.04B derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $5.58B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $7.05B derived: sum of 2 quarters · filed 2015-02-27 | $7.15B derived: sum of 3 quarters · filed 2015-02-27 | $6.90B 10-K · filed 2015-02-27 | $7.21B 10-K · filed 2013-02-28 | |
| 2012-09-30 | $1.48B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.57B derived: sum of 2 quarters · filed 2013-11-08 | $1.32B 10-Q · filed 2013-11-08 | $800.00M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $97.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$151.00M 10-Q · filed 2013-08-09 | -$675.00M derived: sum of 3 quarters · filed 2014-02-28 | -$65.00M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-04-01 | -$248.00M 10-Q · filed 2013-05-10 | -$772.00M derived: sum of 2 quarters · filed 2014-02-28 | -$162.00M derived: sum of 3 quarters · filed 2014-02-28 | $2.20B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2011-12-31 | -$524.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $86.00M derived: sum of 2 quarters · filed 2014-02-28 | $2.45B derived: sum of 3 quarters · filed 2014-02-28 | $1.45B 10-K · filed 2014-02-28 | $1.80B 10-K · filed 2012-02-28 | |
| 2011-10-02 | $610.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.98B derived: sum of 2 quarters · filed 2012-11-09 | $1.97B 10-Q · filed 2012-11-09 | $1.53B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-07-03 | $2.37B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.36B 10-Q · filed 2012-08-09 | $920.00M derived: sum of 3 quarters · filed 2013-02-28 | $1.22B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-04-03 | -$1.00B 10-Q · filed 2012-05-10 | -$1.45B derived: sum of 2 quarters · filed 2013-02-28 | -$1.15B derived: sum of 3 quarters · filed 2013-02-28 | -$1.03B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2010-12-31 | -$441.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$142.00M derived: sum of 2 quarters · filed 2013-02-28 | -$24.00M derived: sum of 3 quarters · filed 2013-02-28 | -$243.00M 10-K · filed 2013-02-28 | ||
| 2010-10-03 | $299.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $417.00M derived: sum of 2 quarters · filed 2011-11-10 | $198.00M 10-Q · filed 2011-11-10 | -$2.06B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-07-04 | $118.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | -$101.00M 10-Q · filed 2011-08-11 | -$2.36B derived: sum of 3 quarters · filed 2012-02-28 | -$367.00M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-04-04 | -$219.00M 10-Q · filed 2011-05-12 | -$2.48B derived: sum of 2 quarters · filed 2012-02-28 | -$485.00M derived: sum of 3 quarters · filed 2012-02-28 | $512.00M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2009-12-31 | -$2.26B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$266.00M derived: sum of 2 quarters · filed 2012-02-28 | $731.00M derived: sum of 3 quarters · filed 2012-02-28 | -$144.00M 10-K · filed 2012-02-28 | ||
| 2009-09-27 | $1.99B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | $2.99B derived: sum of 2 quarters · filed 2010-11-12 | $2.11B 10-Q · filed 2010-11-12 | $2.97B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-06-28 | $997.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $122.00M 10-Q · filed 2010-08-12 | $979.00M derived: sum of 3 quarters · filed 2011-02-28 | $1.42B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-03-29 | -$875.00M 10-Q · filed 2010-05-13 | -$18.00M derived: sum of 2 quarters · filed 2011-02-28 | $427.00M derived: sum of 3 quarters · filed 2011-02-28 | |||
| 2008-12-31 | $857.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $1.30B derived: sum of 2 quarters · filed 2011-02-28 | -$1.28B 10-K · filed 2011-02-28 | |||
| 2008-09-28 | $445.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | -$2.14B 10-Q · filed 2009-11-05 | ||||
| 2008-06-29 | -$2.59B 10-Q · filed 2009-08-06 | |||||
| 2007-12-31 | $1.58B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |